{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:32:44Z","timestamp":1786739564709,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>It has been an established fact that diabetes mellitus (DM) is associated with lower levels of cognitive function and may be a risk factor for the development of mild cognitive impairment (MCI) and dementia. Most of these studies involved elderly diabetes patients and aging itself may contribute to cognitive impairment. Since a majority of the individuals with DM are between the ages of 40 and 59 years, it is crucial to determine the factors that contribute to cognitive impairment in these patients. So this study was done to correlate the various physical and metabolic parameters with MCI in young individuals with type 1 DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>In this cross-sectional study, 126 patients with type 1 DM underwent cognitive assessment by the Montreal Cognitive Assessment test and their cognitive levels were correlated with their HbA1c, lipid profile, and high-sensitivity C-reactive protein (hs-CRP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The prevalence of MCI was 71.42%. MCI was significantly correlated with HbA1c, serum triglycerides, low-density lipoprotein, very low-density lipoprotein, and hs-CRP levels. The factors that were statistically insignificant were the duration of diabetes, body mass index, and high-density lipoprotein levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cognitive impairment is seen even in type 1 DM patients. It should be considered along with the other complications of DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_58_18","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T03:43:00Z","timestamp":1543894980000},"page":"780-784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Mild Cognitive Impairment in Young Type 1 Diabetes Mellitus Patients and Correlation with Diabetes Control, Lipid Profile, and High-sensitivity C-reactive Protein"],"prefix":"10.4103","volume":"22","author":[{"given":"Naveen","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer B.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu L.","family":"Meena","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makhan Lal","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260327","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"R2-20260327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.c3885","article-title":"Designing prevention programmes to reduce incidence of dementia: Prospective cohort study of modifiable risk factors","volume":"341","author":"Ritchie","year":"2010","journal-title":"BMJ"},{"key":"R3-20260327","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jns.2012.07.046","article-title":"Cognitive dysfunction profile and arterial stiffness in type 2 diabetes","volume":"322","author":"Mehrabian","year":"2012","journal-title":"J Neurol Sci"},{"key":"R4-20260327","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: A cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann Intern Med"},{"key":"R5-20260327","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2007-0034","article-title":"Cognitive dysfunction and diabetes mellitus","volume":"29","author":"Kodl","year":"2008","journal-title":"Endocr Rev"},{"key":"R6-20260327","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1464-5491.2001.00577.x","article-title":"Cognitive function and information processing in type 2 diabetes","volume":"18","author":"Cosway","year":"2001","journal-title":"Diabet Med"},{"key":"R7-20260327","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1007\/s00125-005-0023-4","article-title":"Cognitive decline and dementia in diabetes systematic overview of prospective observational studies","volume":"48","author":"Cukierman","year":"2005","journal-title":"Diabetologia"},{"key":"R8-20260327","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: A systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurology"},{"key":"R10-20260327","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/2278-330X.114142","article-title":"Revision of Prasad's social classification and provision of an online tool for real time updating","volume":"2","author":"Sharma","year":"2013","journal-title":"South Asian J Cancer"},{"issue":"Suppl 1","key":"R12-20260327","first-page":"S8","article-title":"Classification and diagnosis of diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"R13-20260327","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-199921020-00004","article-title":"Drug-induced cognition disorders in the elderly: Incidence, prevention, and management","volume":"21","author":"Gray","year":"1999","journal-title":"Drug Saf"},{"key":"R14-20260327","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"key":"R16-20260327","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.18203\/2320-6012.ijrms20161794","article-title":"The spectrum of mild cognitive impairment in dyslipidemic nonelderly type 1 diabetics","volume":"4","author":"Kumar","year":"2016","journal-title":"Int J Res Med Sci"},{"key":"R17-20260327","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/2230-8210.155372","article-title":"Type 1 diabetes in India: Overall insights","volume":"19","author":"Das","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"R18-20260327","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2337\/dc07-2132","article-title":"Cognitive function in children with type 1 diabetes: A meta-analysis","volume":"3","author":"Gaudieri","year":"2008","journal-title":"Diabetes Care"},{"key":"R19-20260327","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S1355617713001434","article-title":"Cognitive functioning in young children with type 1 diabetes","volume":"20","author":"Cato","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"key":"R20-20260327","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2337\/diacare.21.3.379","article-title":"Neuropsychological complications of IDDM in children 2 years after disease onset","volume":"21","author":"Northam","year":"1998","journal-title":"Diabetes Care"},{"key":"R21-20260327","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/diacare.23.10.1486","article-title":"Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes","volume":"23","author":"Ryan","year":"2000","journal-title":"Diabetes Care"},{"key":"R22-20260327","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s125-002-8250-6","article-title":"Impaired intellectual development in children with type 1 diabetes: Association with HbA1c, age at diagnosis and sex","volume":"45","author":"Schoenle","year":"2002","journal-title":"Diabetologia"},{"key":"R23-20260327","first-page":"171","article-title":"The prevalence of cognitive impairment amongst type 2 DM patients at Abakaliki South-East Nigeria","volume":"4","author":"Eze","year":"2015","journal-title":"J Metab Syndr"},{"key":"R24-20260327","first-page":"246","article-title":"Prevalence and pattern of cognitive dysfunction in type 2 diabetes mellitus","volume":"2","author":"Kataria","year":"2013","journal-title":"Int J Med and Appl Sci"},{"key":"R25-20260327","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0165-0173(97)00003-9","article-title":"Central nervous system complications of DM: A perspective from the blood-brain barrier","volume":"23","author":"Mooradian","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"R26-20260327","first-page":"S187","article-title":"Effects of their nutrient precursors on the synthesis and release of serotonin, the catecholamines, and acetylcholine: Implications for behavioral disorders","volume":"11","author":"Wurtman","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"R27-20260327","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(96)00727-5","article-title":"Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: A molecular study","volume":"736","author":"Figlewicz","year":"1996","journal-title":"Brain Res"},{"key":"R28-20260327","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diab.44.2.147","article-title":"Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression","volume":"44","author":"Sipols","year":"1995","journal-title":"Diabetes"},{"key":"R29-20260327","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2337\/diabetes.49.2.244","article-title":"Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expressions in rats","volume":"49","author":"Havel","year":"2000","journal-title":"Diabetes"},{"key":"R30-20260327","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.802225","article-title":"Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study","volume":"27","author":"Elias","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R31-20260327","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1046\/j.0742-3071.2001.00571.x","article-title":"Factors associated with plasma lipids and lipoproteins in type 1 DM: The Eurodiab IDDM Complications Study","volume":"18","author":"Idzior-Walus","year":"2001","journal-title":"Diabet Med"},{"key":"R32-20260327","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6065\/apem.2014.19.4.191","article-title":"Serum lipid profiles and glycemic control in adolescents and young adults with type 1 DM","volume":"19","author":"Kim","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"R33-20260327","first-page":"99","article-title":"Prevalence of dyslipidemia in young adult Indian population","volume":"56","author":"Sawant","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"R34-20260327","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.2337\/dc11-0958","article-title":"Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment","volume":"34","author":"Chen","year":"2011","journal-title":"Diabetes Care"},{"key":"R35-20260327","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0891-6632(88)80011-4","article-title":"Triglyceride levels affect cognitive function in noninsulin-dependent diabetics","volume":"2","author":"Perlmutter","year":"1988","journal-title":"J Diabet Complications"},{"key":"R36-20260327","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db09-1163","article-title":"Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes","volume":"59","author":"Marioni","year":"2010","journal-title":"Diabetes"},{"key":"R37-20260327","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2337\/dc16-0316","article-title":"Association of plasma DPP4 activity with mild cognitive impairment in elderly patients with type 2 diabetes: Results from the GDMD study in China","volume":"39","author":"Zheng","year":"2016","journal-title":"Diabetes Care"},{"key":"R38-20260327","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"R39-20260327","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00125-010-1883-9","article-title":"Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: An 18-year follow-up of diabetes control and complications trial (DCCT) cohort","volume":"54","author":"Jacobson","year":"2011","journal-title":"Diabetologia"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02223308-201822060-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:03Z","timestamp":1786735803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02223308-201822060-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_58_18","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}